Treatment of metastatic invasive moles in two husband-side sisters-in-law. Case reports and review of literature

Purpose of investigation: The treatment of "high risk" persistent trophoblastic disease (PTD) consists of poly-chemotherapy. This policy probably will lead to overtreatment of some patients. Also, familiar molar pregnancies through the paternal line are unknown in the literature up till now.

Methods: We describe two cases of "high risk" PTD in two husband-side sisters-in-law, in which poly-chemotherapy was stopped after histology became available and showed invasive metastatic mole.

Conclusion: It should be stressed that treatment decisions should be made based on the concept of "high" or "low" risk PTD, but if histology becomes available, chemotherapy might be less aggressive in cases of invasive mole. If invasive mole could be familiar through the paternal line remains unclear with the current knowledge of genetics in trophoblastic disease.

Persistent trophoblastic disease; Metastatic invasive mole; Familiar invasive mole

[1] Lewis J.: "Diagnosis and management of gestational trophoblastic disease". Cancer, 1993, 71, 1639.

[2] Kajii T., Ohama K.: "Androgenetic origin of hydatidiform mole" Nature, 1977, 268, 633.

[3] Ring A. M.: "The concept of benign metastasizing hydatidiform moles". Am. J. Clin. Path., 1972, 58, 111.

[4] Lurain J. R., Brewer J. I.: "Invasive mole". Semin. Oneal., 1982, 9, 174.

[5] Bagshawe K. D., Dent J., Webb J.: "Hydatidiform mole in the United Kingdom 1973 - 1983". Lancet, 1986, ii, 673.

[6] Rustin G. J. S.,B ooth M.. Dent J.: "Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours". Br. Med. J.. 1984, 288, 103.

[7] Okamoto T.,N omura S.,N akanishi T.,G oto S.,T omoda Y.,M 1zutani M.: "Choriocarcinoma diagnostic score: a scoring system to differentiate choriocarcinoma from invasive mole". In t. J. Gynecol. Cancer, 1998, 8, 128.

[8] Fulop V., Colitti C. V., Genest D.,B erkowitz R. S.,Y iu G. K.. Ng S., Szepesi J., Mok S. M.: "DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic disease". Oncogene, 1998, 17, 419.